Evidence map›Paper›PMID 42073619›Full record

ArticleCancers2026

Evaluation of Ovarian Function Suppression Failure in Premenopausal Women with Early-Stage Breast Cancer.

Catherine Côté, Maïka Wild, Lauriann Roussel, Julia Hoang, David Simonyan, Christian Laflamme, Julie Lemieux

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Catherine CôtéDepartment of Medicine, University Laval, Quebec, QC G1V 0A6, Canada.ORCID 0000-0001-5331-516X
Maïka WildDepartment of Medicine, University Laval, Quebec, QC G1V 0A6, Canada.
Lauriann RousselDepartment of Medicine, University Laval, Quebec, QC G1V 0A6, Canada.
Julia HoangDepartment of Medicine, University Laval, Quebec, QC G1V 0A6, Canada.
David SimonyanClinical and Evaluative Research Platform, CHU de Québec-Université Laval Research Centre, Quebec, QC G1V 4G2, Canada.ORCID 0000-0001-8826-7428
Christian LaflammeOncology Axis, CHU de Québec-Université Laval Research Centre, Quebec, QC G1S 4L8, Canada.
Julie LemieuxOncology Axis, CHU de Québec-Université Laval Research Centre, Quebec, QC G1S 4L8, Canada.

Funding

CHU de Québec-Université Laval Clinical Research Grant 2024
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant endocrine treatmentgonadotropin-releasing hormone agonisthormone receptor-positive early breast cancerovarian suppressionpremenopausal

Identifiers

PMID42073619
PMCPMC13115181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.